Nagging People to Eat Healthily Does Not Work (Economist)
- Design
- Reportage
- Participants
- Mexico: monthly manufacturer sales data (EMIM) 2017–2022, seven categories covering >90% of packaged food subject to labelling
- Journal
- Social Science & Medicine (Garduño-Alanis et al., 2026)
- Read via
- The Economist (lede + Genetic Literacy Project reprint) + Global Food Research Program summary of the Mexico study
Design and size bound what a finding can claim. A press release or news report is a layer on top of the study, not the study.
Original: www.economist.com/international/2026/10/08/nagging-people-to-eat-healthily-does-not-work
Nagging People to Eat Healthily Does Not Work (Economist)
Summary
The capture holds only the opening scene (oblea stalls in Bogotá's Simón Bolívar park: "Life's too short not to eat the food that you love"). The article's body, recovered from a Genetic Literacy Project reprint, argues that decades of exhortation and mild nudging have not curbed obesity, so governments are shifting from persuading individuals to re-engineering the food environment — warning labels, taxes, sales and placement rules. The strongest evidence comes from Mexico, where most of the measured calorie reduction came from manufacturers reformulating products, not from consumers choosing differently.
Key claims (with numbers)
- Colombia: about a quarter of adults are obese, a fivefold rise since 1980. Since 2022, processed foods high in sugar, salt or unhealthy fat carry black warning labels and a tax that started at 10% and has risen to 20% (15% in 2024, 20% in 2025).
- Britain: between 1992 and 2020 the country adopted 689 anti-obesity policies, only two of which created a financial disincentive; England's obesity rate doubled anyway.
- GLP-1 drugs (GLP-1s) offer hope but are expensive and must be taken indefinitely — framed as not a population-level substitute for policy.
- Mexico (2020 front-of-pack warning labels): calories sold fell 15% and added sugar 25%; roughly 90% of the calorie drop came from reformulation. The underlying study — Garduño-Alanis, Salgado, Barquera et al., Social Science & Medicine 2026 (GFRP summary) — compares observed sales with pre-policy trends across Jan 2017–Dec 2022 and also reports saturated fat −12%, sodium −7%, about 65 fewer calories per person per day, and a ≥5% rise in fibre sold. The 90% reformulation share is a co-author's (Salgado) estimate.
- Mexico sugary-drink tax: sales down roughly 6% in its first year.
- Industry workarounds: when Britain banned junk food at checkouts, exempt fresh pastries took its place; officials now consider healthiness targets for total supermarket sales.
- Nesta (think-tank): modest changes to a quarter of basket items could cut calories by 8.5%, potentially halving obesity.
- A Nature study found ten European countries charge higher VAT on fruit and vegetables than on meat and dairy; Denmark, Germany and the Netherlands are discussing reversing the imbalance.
- Elsewhere: California requires grocers to place healthy foods in high-traffic areas; Scotland has curbed prominent displays and bulk-buy deals on unhealthy foods; India is weighing a ban on junk-food sales near schools.
Flagged as unproven or limited
- The Mexico numbers measure sales, not consumption or body weight; no obesity outcome is yet attributable to the labels.
- The 90% reformulation share is an author estimate, not a reported model output.
- Narrow rules invite substitution (the pastry effect); the effect of whole-basket targets is untested.
- Colombia's tax is too recent for outcome data; the article reports design, not results.
Connections
- Dietary Nudging — concept page: why information and exhortation fail and environment-level rules do better.
- GLP-1s — the pharmacological alternative the article sets aside on cost.
- Food Fads — the demand side the same policies must contend with.
- The Economist
Captured-by trigger
Source file: raw/processed/Economist 2026-10-10 International - Nagging people to eat healthily does not work.md (lede only; body recovered from a reprint, Mexico study identified and read via GFRP).
Research notes, not medical advice. Findings are reported with the population, dose and duration they were measured in; whether they transfer to you is a question for a clinician.